AVROBIO - Model AVR-RD-05 - Therapy for Hunter Syndrome
AVROBIO has a preclinical research program for mucopolysaccharidosis type II (MPS II), or Hunter syndrome. The program is being developed in collaboration with Brian Bigger, Ph.D., who has published favorable preclinical data in a mouse model of Hunter syndrome.
-
Most popular related searches
Customer reviews
No reviews were found for AVROBIO - Model AVR-RD-05 - Therapy for Hunter Syndrome. Be the first to review!